Legislation

Title: Pharmacists - Required Notification and Authorized Substitution - Lower-Costing Drugs, Medical Devices, and Biological Products
Sponsored by: Chair, Health and Government Operations Committee (By Request - Departmental - Health)
Status: In the House - Hearing 2/25 at 1:00 p.m.
Analysis: Fiscal and Policy Note

Synopsis

Requiring a pharmacist or a pharmacist's designee who is under certain supervision to inform a certain consumer of the availability of certain therapeutically equivalent drugs, substantially equivalent medical devices, or interchangeable biological products and the cost difference between those drugs, devices, or products and certain prescribed drugs, medical devices, or biological products; etc.

Committees

Original:: Health and Government Operations Click to view Recorded Media

Committee Testimony

Witness List

Details

Bill File Type: Regular

Effective Date(s): January 1, 2021

By Request of the Governor

History

Legislation History
Chamber House Calendar Date 1/29/2020 Legislative Date 1/29/2020 Action First Reading Health and Government Operations Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Pharmacists - Required Notification and Authorized Substitution - Lower-Costing Drugs, Medical Devices, and Biological Products Proceedings
Chamber House Calendar Date 1/30/2020 Legislative Date 1/30/2020 Action Hearing 2/25 at 1:00 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
House	1/29/2020	1/29/2020	First Reading Health and Government Operations
			Text - First - Pharmacists - Required Notification and Authorized Substitution - Lower-Costing Drugs, Medical Devices, and Biological Products
House	1/30/2020	1/30/2020	Hearing 2/25 at 1:00 p.m.

File Code

Subjects

Statutes